Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 15;15(10):e0240746.
doi: 10.1371/journal.pone.0240746. eCollection 2020.

Genes regulating membrane-associated E-cadherin and proliferation in adenomatous polyposis coli mutant colon cancer cells: High content siRNA screen

Affiliations

Genes regulating membrane-associated E-cadherin and proliferation in adenomatous polyposis coli mutant colon cancer cells: High content siRNA screen

Lauren E King et al. PLoS One. .

Abstract

Truncating mutations in the tumour suppressor gene APC occur frequently in colorectal cancers and result in the deregulation of Wnt signalling as well as changes in cell-cell adhesion. Using quantitative imaging based on the detection of membrane-associated E-cadherin, we undertook a protein coding genome-wide siRNA screen to identify genes that regulate cell surface E-cadherin in the APC-defective colorectal cancer cell line SW480. We identified a diverse set of regulators of E-cadherin that offer new insights into the regulation of cell-cell adhesion, junction formation and genes that regulate proliferation or survival of SW480 cells. Among the genes whose depletion promotes membrane-associated E-cadherin, we identified ZEB1, the microRNA200 family, and proteins such as a ubiquitin ligase UBE2E3, CDK8, sorting nexin 27 (SNX27) and the matrix metalloproteinases, MMP14 and MMP19. The screen also identified 167 proteins required for maintaining E-cadherin at cell-cell adherens junctions, including known junctional proteins, CTNND1 and CTNNA1, as well as signalling enzymes, DUSP4 and MARK2, and transcription factors, TEAD3, RUNX2 and TRAM2. A better understanding of the post-translational regulation of E-cadherin provides new opportunities for restoring cell-cell adhesion in APC-defective cells.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Detection of membrane associated E-cadherin in SW480 cells.
Representative images from the screen showing nuclei and E-cadherin staining and the E-cadherin detection algorithm. Cells were treated with siRNA: (A) siZEB1 (increased Ecad), (B) siCDH1 (decreased Ecad) and (C) mock controls. 72 hours later the cells were fixed, permeabilized and stained with Hoechst and αE-cadherin (HECD1). Immunofluorescent images were taken at 20x on the Cellomics ArrayScan. An E-cadherin detection algorithm was applied to the images: Scale bars; 50μm in both upper panels and insert. (D) The quantitation of membrane associated E-cadherin from a representative 384-well plate. Ecad score = average number of E-cadherin fibres detected per cell in a well. The Ecad score was averaged over replicate wells and normalised to the number of control (mock transfected) wells contained on every plate (Ecad score, mock n = 16 wells, siZEB1 and siCDH1, n = 6 wells, mean ± SD). (E) Expression of ZEB1 in SW480 cells treated with individual siRNA duplexes from the SMARTpool (siZEB1 #1–4, as indicated). ZEB1 expression is reduced with each siRNA duplex. The blot is representative of three individual experiments. Shown are cropped images, uncropped blots are included in S1 Raw images; Quantitation of ZEB1 is shown below (mean± SEM) (n = 3). Protein levels were determined using densitometry against the loading control β-tubulin *p<0.05 (exact p values are indicated); one-tailed unpaired t-test vs mock control.
Fig 2
Fig 2. A genome-wide imaging based siRNA screen identifies regulators of membrane-associated E-cadherin in SW480 colon cancer cells.
(A) Membrane associated Ecad scores normalised to mock transfectants for all SMARTpool siRNAs (black) transfected into SW480 cells. Controls are highlighted: mock (blue), siZEB1 (orange), siCDH1 (red) & siPLK1 (green). (B) Mock normalised Robust Z-score (Ecad) plot for SMARTpool siRNA screen. The cut-off for E-cadherin negative regulatory genes is indicated by the red-dotted line (Z-score>5.16); the Z- score cut-off for positive regulatory genes is <0.036. (C) Normalised Robust Z-score (Ecad) (Z-score Ecad) is shown for genes with a functional association with E-cadherin regulation and a gene* with potential miRNA-200 family off-target effects.
Fig 3
Fig 3. Effect of siUBE2E3 on SW480 membrane-associated E-cadherin.
SW480 cells were transfected with individual siRNA duplexes from the UBE2E3 SMARTpool for 72 hours: (A) Expression of ZEB1, E-cadherin and UBE2E3 were analysed by immunoblot. β-tubulin was used as a loading control. siRNA#1 (1*) shares the same 5’ nucleotide sequence as miR200 family seed sequence. The blot is representative of three individual experiments. Shown are cropped images, uncropped blots are included in S1 Raw images; (B) Quantitation of E-cadherin, ZEB1 and UBE2E3 protein levels upon siUBE2E3 knockdown in SW480 cells. Protein levels were determined using densitometry against the loading control β-tubulin and are representative for triplicate experiments (mean± SEM) *p<0.05 (p = 0.026 and p = 0.039 for si UBE2E3 1 and 3, respectively), **p<0.005 (p = 0.00247), ***p<0.001 for E-cadherin and UBE2E3 or duplicate experiments (mean ± sd) for ZEB1 *p = 0.023, **p = 0.0035, ***p<0.001; one-tailed unpaired t-test vs mock control; (C) Immunofluorescence staining of E-cadherin in fixed SW480 cells, 72 hours post treatment with siUBE2E3 siRNA duplexes #1, 2, 3 or mock control. Scale bar; 50μM.
Fig 4
Fig 4. siRNAs which alter SW480-membrane-associated E-cadherin.
(A) Summary of the outcome of the secondary validation screen. The number of active siRNA for E-cadherin negative and positive regulators are indicated. At least 2 out of 4 siRNA duplexes must statistically recapitulate the primary SMARTpool screen to be considered a hit. (B) Representative images from the deconvoluted screen of αE-cadherin and Hoechst staining, 72 hours post transfection of positive regulators with selected duplex siRNAs (25nM) for mock, CTNNBIP1, CTNND1, DOCK3, DUSP4 and ITGB4. Scale bar; 50 μM, 20x magnification. (C and D) Functional categorization of candidate E-cadherin positive (C) and negative (D) regulatory genes identified from the screen (Panther Classification GO-Slim Molecular Functions, System Version 15.0).
Fig 5
Fig 5. SW480-membrane associated E-cadherin can increase when negative regulators are knocked down.
Representative images from the deconvoluted screen of αE-cadherin, 72 hours post transfection of selected duplex siRNAs (25nM, duplex # indicated in brackets) for mock, ZEB1, CDK8, SNX27, EPS8L1 and ZNF518A. Scale bar; 50 μM, 20x magnification with enlarged images for E-cadherin shown below. Hoechst staining shows cell nuclei. Mock normalised Ecad score for individual siRNA (numbered 1–4) in the deconvolution screen is shown below.
Fig 6
Fig 6. Model for the regulation of junctional E-cadherin.
Schematic representation of biological processes identified in the siRNA screen for regulation of membrane-associated E-cadherin: 1. Gene transcription; 2. miR regulation (eg miR200 family); 3. Recycling of anti-adhesive or retention of pro-adhesive cargo by SNX27; 4. Inhibition of β-catenin/Tcf transcription; 5. Lysosomal or proteosomal degradation; 6. Translocation; 7. MMP14/MMP19-mediated regulation. Negative (red) and positive (green) arrows and boundaries indicate regulation of membrane-associated E-cadherin are indicated.

Similar articles

Cited by

References

    1. Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, et al. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proceedings of the National Academy of Sciences of the United States of America. 2001;98(18):10356–61. 10.1073/pnas.171610498 - DOI - PMC - PubMed
    1. Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis—a look outside the nucleus. Science. 2000;287(5458):1606–9. 10.1126/science.287.5458.1606 - DOI - PubMed
    1. Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell. 2012;149(6):1192–205. 10.1016/j.cell.2012.05.012 - DOI - PubMed
    1. Nathke IS, Adams CL, Polakis P, Sellin JH, Nelson WJ. The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration. The Journal of cell biology. 1996;134(1):165–79. 10.1083/jcb.134.1.165 - DOI - PMC - PubMed
    1. Sansom OJ, Reed KR, Hayes AJ, Ireland H, Brinkmann H, Newton IP, et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes & development. 2004;18(12):1385–90. - PMC - PubMed

Publication types

MeSH terms